Compare · PBAX vs VZIO
PBAX vs VZIO
Side-by-side comparison of Phoenix Biotech Acquisition Corp. (PBAX) and VIZIO Holding Corp. (VZIO): market cap, price performance, sector, and recent activity on the wire.
Summary
- PBAX operates in Industrials, while VZIO operates in Consumer Staples - the two are in different parts of the market.
- VZIO is the larger of the two at $2.56B, about 11.3x PBAX ($227.7M).
- VZIO has more recent analyst coverage (9 ratings vs 0 for PBAX).
- Company
- Phoenix Biotech Acquisition Corp.
- VIZIO Holding Corp.
- Price
- $5.45+14.26%
- $11.37-0.13%
- Market cap
- $227.7M
- $2.56B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Consumer Electronics/Appliances
- Consumer Electronics/Appliances
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- 2021
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 9
Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in the life sciences sector. The company was incorporated in 2021 and is based in Oakland, California.
VIZIO Holding Corp.
VIZIO Holding Corp., through its subsidiaries, provides smart televisions, sound bars, and accessories in the United States. It also operates Platform+ that comprises SmartCast, a Smart TV operating system, enabling integrated home entertainment solution, and data intelligence and services products through Inscape. Its SmartCast delivers content and applications through an easy-to-use interface, as well as supports streaming apps and hosts its free ad-supported video app, WatchFree, and VIZIO Free Channels. In addition, the company provides support for third-party voice platforms. It sells its products to retailers and through online channels. The company was incorporated in 2002 and is headquartered in Irvine, California.
Latest PBAX
- Phoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
- Phoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Leadership Update, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (Amendment)
- New insider Corey Daniel claimed ownership of 671,470 shares (SEC Form 3) (Amendment)
- SEC Form D filed by Phoenix Biotech Acquisition Corp.
- SEC Form SC 13G/A filed by Phoenix Biotech Acquisition Corp. (Amendment)
- SEC Form 4 filed by Laporte Kathleen (Amendment)
- Atwood Brian G acquired 248,735 shares (SEC Form 4) (Amendment)
- SEC Form SC 13D/A filed by Phoenix Biotech Acquisition Corp. (Amendment)
- Loewy Caroline M acquired 5,828 shares (SEC Form 4)
- Kosacz Barbara acquired 5,828 shares (SEC Form 4)
Latest VZIO
- VIZIO Launches App Bundle With a Special STARZ and AMC+ Offer
- SEC Form 15-12G filed by VIZIO Holding Corp.
- SEC Form EFFECT filed by VIZIO Holding Corp.
- Director Burbank John R returned 76,953 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Russell David Eugene returned 2,820,301 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Free Vicky returned 80,547 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Officer O'Donnell Michael Joseph returned 602,364 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Mohan Rajendra M returned 53,829 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Chief Executive Officer Wang William Wei returned 2,281,744 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Chief Financial Officer Townsend Adam R. returned 704,903 shares to the company, closing all direct ownership in the company (SEC Form 4)